Home News Nigeria Secures ICH Membership, Strengthening Global Pharmaceutical Standards

Nigeria Secures ICH Membership, Strengthening Global Pharmaceutical Standards

0
Nigeria Secures ICH Membership, Strengthening Global Pharmaceutical Standards

 

Nigeria has been officially admitted as a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), marking a significant milestone for the nation’s regulatory and pharmaceutical landscape.

The National Agency for Food and Drug Administration and Control (NAFDAC) secured the membership during the ICH Assembly held in Singapore from November 18 to 19, 2025 — the council’s second in-person meeting this year.

At the same assembly, South Africa’s SAHPRA was also admitted as a member, while DIGEMAPS of the Dominican Republic and the Philippine FDA joined as Observers.

With these additions, the 35-year-old ICH now comprises 25 Members and 41 Observers.

Membership criteria for national regulatory authorities include the implementation of at least three Tier 1 ICH Guidelines — Q1 (Stability Testing), Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients), and E6 (Good Clinical Practice). Members are also required to participate in biannual meetings and demonstrate a plan to implement all ICH guidelines.

ICH serves as a global platform bringing together regulatory authorities and the pharmaceutical industry to harmonise scientific and technical requirements for drug development. Its work ensures that medicines developed and registered across member countries meet consistent standards of safety, quality, and efficacy.